Regeneron Pharmaceuticals (REGN.VI) Q3 2018 Earnings

2AugConfirmed
Q4 2017
Q1 2018
Q2 2018
Q3 2018
3.29
3.76
4.23
4.7

Details

Expected EPS
4.0110435
Actual EPS
4.7011155
Surprise EPS
0.69
Surprise Percent
+17.2%

Description

Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 4.7011155 per share for Q3 2018.

0 Comments

Share your thoughts